Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus

OBJECTIVES: We compared the outcomes of patients with or without systemic lupus erythematosus (SLE) who were diagnosed with coronavirus disease 19 (COVID-19) and evaluated factors within patients with SLE associated with severe outcomes. METHODS: This retrospective cohort study used the deidentified...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruera, Sebastian, Lei, Xiudong, Zhao, Hui, Yazdany, Jinoos, Chavez-MacGregor, Mariana, Giordano, Sharon H, Suarez-Almazor, Maria E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Co-Morbidities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929928/
https://www.ncbi.nlm.nih.gov/pubmed/36787921
http://dx.doi.org/10.1136/lupus-2022-000750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929928/
https://www.ncbi.nlm.nih.gov/pubmed/36787921
http://dx.doi.org/10.1136/lupus-2022-000750

Ejemplares similares